Skip to main content

Table 1 Clinicopathological data of patients with NMIBC

From: Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing

Clinicopathological variants

BCG group (n = 46)

EPI group (n = 12)

Total (n = 58)

P-value

Gender

   

0.432

 Male

35

11

46

 

 Female

11

1

12

 

Preoperative age (years)

   

0.336

 ≤ 60

18

7

25

 

 60–70

19

4

23

 

 > 70

9

1

10

 

Smoking history

   

0.331

 No

25

4

29

 

 Yes

21

8

29

 

Prior recurrence rate

   

0.233

 Primary

27

5

32

 

 Recurrent, ≤ 1 rec/year

11

2

13

 

 Recurrent, > 1 rec/year

8

5

13

 

T category

   

0.012

 Ta

29

12

41

 

 T1

17

0

17

 

Grade

   

0.331

 Low grade

21

8

29

 

 High grade

25

4

29

 

Tumor size (cm)

   

0.759

 < 3

26

8

34

 

 ≥ 3

20

4

24

 

No. tumors

   

0.891

 ≤ 3

34

8

42

 

 > 3

12

4

16

 

Risk stage

   

0.291

 Intermediate risk

19

5

26

 

 High risk

27

5

32

 

EORTC risk tables

   

0.956

 1–4

17

3

20

 

 5–9

24

9

33

 

 10–17

5

0

5

 

CUETO scoring model

   

0. 866

 0–4

13

3

16

 

 5–6

16

5

21

 

 7–9

15

4

19

 

 10–16

2

0

2

 
  1. NMIBC: non-muscle invasive bladder cancer; n: number of patients; No: number; Recurrent, ≤ 1 rec/year: prior recurrence rate of less than one per year; Recurrent, > 1 rec/year: prior recurrence rate of more than one per year; EORTC: European Organization for Research and Treatment of Cancer; CUETO: Spanish Urological Club for Oncological Treatment